Even more frightening than the ineffective CMO impostors are some of the new drugs now being researched for arthritis. For example, a biotech firm, the Immunex Corporation of Seattle, is trying to resurrect a failed cancer drug and promote its use for arthritis. The company spent billions of dollars developing a drug that turned out to be a total flop for cancer. Now, in an attempt to try to salvage its investment, it is greedily trying to find a way to cram this very dangerous drug into the anti-arthritis category. We find that unconscionable and immoral.
The Wall Street Journal reports, “Scientists are racing to resurrect a set of experimental medicines that figured in one of the most notorious scientific debacles of the biotechnology industry’s short history… The category of drugs largely failed in treating a lethal blood infection. Biotechnology analysts say the success of these new anti-inflammatory medicines is crucial to the industry, which has been in a research slump of late.”
The article continues, “Researchers worry that the new treatments will cause long-term side effects, harming patients’ immune systems and increasing the risk of contracting other serious diseases. In fact, human tests were recently suspended for one experimental arthritis drug, CE9.1, being developed by IDEC Pharmaceuticals Corporation and SmithKline Beecham PLC. Researchers at those companies encountered worrisome and unexplained immune system effects with the drug.”
Worrisome, indeed, because these drugs are immunosuppressants that can impair immune response to attacking microorganisms or the formation of cancerous tumours. Many experts are fearful. “I think we could cure rheumatoid arthritis by using a combination of the new
medicines, says Dr. Moreland from Alabama. “The problem is, will you have a viable person left after that?”
Existing immunosuppressants like Methotrexate (also called Rheumatrex) designed for the treatment cancer are altogether too liberally prescribed for arthritis. But it’s no wonder doctors get pushed by their desperate patients into prescribing such horrible drugs. The Physicians’ Desk Reference of pharmaceutical drugs (the doctor’s oversized “drug bible”) contains 4 1/2 columns of fine-print precautions contraindications, adverse reactions, and warnings about the side effects of Methotrexate. It states, “There is a potential for severe toxic reactions.” It is one of the most toxic drugs made. And doctors know it. Yet when suffering patients plead for their doctor to “please, please do something for me,” the temptation to prescribe damaging drugs like Methotrexate or cortisone becomes altogether too strong. We’ve seen livers so badly damaged from Methotrexate and\or cortisone that CMO was completely ineffective for those unfortunate patients.
As an immunosuppressant, Methotrexate also inhibits the action of many of the chemicals that are a vital part of the immune system’s defences against invading organisms that cause serious diseases. This is also true of the new drugs from Centocor Inc., Synergen Inc., and Amgen Inc., as well as IDEC. They inhibit the production or action of protective substances like Tumour Necrosis Factor (TNF) and interleukin-1 (IL-1), which could leave a person much more susceptible to cancerous tumours and other diseases, including those caused by invasive viruses and bacteria.
While the arduous process of conventional drug research drags on, the answer is already available in nature. CMO, the natural immunomodulator, already does exactly what those billion dollar projects are looking for. CMO is already clinically proved to be effective against arthritis. It is most important to understand that CMO is not an immune suppressant. Nor is it an immune stimulant. It is an immune modulator. This natural immunomodulator neither suppresses nor stimulates the immune system. It regulates, normalizes, corrects, and controls only those functions within the immune system that have gone amiss.
It does nothing to inhibit proper immune function or response. It acts only on immune programs that have gone awry. That’s why, in thousands of patients, it has been shown to have absolutely no negative side effects.
The only ‘side effects’ so far encountered have been beneficial: lowering high blood pressure, reducing the need for insulin, reducing the inflammation in the lungs of emphysema patients, correcting the blood sedimentation rate of lupus patients, etc. Those are the kinds of ‘side effects’ doctors love to see.
Moreover, CMO is presented in capsule form to be taken orally. The others, which are drugs rather than naturally derived substances, require either slow hypo- dermic drip infusion or several injections every week. With CMO, however, the benefits seem to be permanent or, at least, long lasting. Once the faulty immune programs are normalized, they seem to stay that way.
Furthermore, CMO works for osteoarthritis as well as rheumatoid. (What those multi-million-dollar scientists don’t seem to realize yet is that evidence suggests that autoimmune misprogramming is involved in just about all types of arthritis.)
Considering the success of CMO in its clinical study, the extraordinary results in practical use by physicians, the absence of side effects, success with thousands of users, and its immediate availability to the public, CMO certainly warrants serious consideration as an option for anyone with arthritis.
Try it. It does more than stop the pain. It stops the destruction of your joints as well. Try it. You’ll wish you’d done it sooner.
*69\142\2*
